Cancer Research Annual Meeting 2010  Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, D.
Right arrow Articles by Barraclough, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, D.
Right arrow Articles by Barraclough, R.
[Cancer Research 65, 3796-3805, May 1, 2005]
© 2005 American Association for Cancer Research


Cell and Tumor Biology

Human Homologue of Cement Gland Protein, a Novel Metastasis Inducer Associated with Breast Carcinomas

Dong Liu1, Philip S. Rudland1,2, D. Ross Sibson3, Angela Platt-Higgins2 and Roger Barraclough2

1 Cancer Tissue Bank Research Centre and 2 School of Biological Sciences, University of Liverpool, Liverpool, United Kingdom and 3 Clatterbridge Cancer Research Trust, J.K. Douglas Laboratories, Clatterbridge Hospital, Wirral, United Kingdom

Requests for reprints: Roger Barraclough, Biosciences Building, University of Liverpool, Crown Street, Liverpool L69 7ZB, United Kingdom. Phone: 44-151-795-4469; Fax: 44-151-795-4406; E-mail: brb{at}liv.ac.uk.

A suppression subtractive cDNA library representing mRNAs expressed at a higher level in the malignant human breast cancer cell line, MCF-7, relative to a benign breast tumor-derived cell line, Huma 123, contained a cDNA, M36, which was expressed in estrogen receptor {alpha} (ER{alpha})–positive breast carcinoma cell lines but not in cell lines from normal/benign/ER{alpha}-negative malignant breast lesions. M36 cDNA had an identical coding sequence to anterior gradient 2 (AGR2), the human homologue of the cement gland–specific gene (Xenopus laevis). Screening of breast tumor specimens using reverse transcription-PCR and immunocytochemistry with affinity-purified anti-AGR2 antibodies showed that the presence of AGR2 mRNA and protein were both statistically significantly associated with ER{alpha}-positive carcinomas (P = 0.007, Fisher's exact test) and with malignancy (P ≤ 0.025). When an expression vector for AGR2 cDNA was introduced into benign nonmetastatic rat mammary tumor cells, and three separate clones and two pools of cells were transferred to the mammary glands of syngeneic hosts, there were no consistent differences in the mean latent periods of tumor formation. However, metastases occurred in the lungs of animals receiving the AGR2 transfectants in 77% to 92% of animals with primary tumors (P = 0.0001) compared with no metastases in the control groups. The AGR2 transfectants exhibited enhanced rates of adhesion to a plastic substratum and extracellular AGR2 enhanced the rate of attachment of AGR2-negative but not AGR2-positive cells. These experiments are the first to link mechanistically the developmental gene product, AGR2, with metastasis in vivo.




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
D. L. Barraclough, A. Platt-Higgins, S. de Silva Rudland, R. Barraclough, J. Winstanley, C. R. West, and P. S. Rudland
The Metastasis-Associated Anterior Gradient 2 Protein Is Correlated with Poor Survival of Breast Cancer Patients
Am. J. Pathol., November 1, 2009; 175(5): 1848 - 1857.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. Zhao, B. Y. Lee, D. A. Brown, M. P. Molloy, G. M. Marx, N. Pavlakis, M. J. Boyer, M. R. Stockler, W. Kaplan, S. N. Breit, et al.
Identification of Candidate Biomarkers of Therapeutic Response to Docetaxel by Proteomic Profiling
Cancer Res., October 1, 2009; 69(19): 7696 - 7703.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S.-W. Park, G. Zhen, C. Verhaeghe, Y. Nakagami, L. T. Nguyenvu, A. J. Barczak, N. Killeen, and D. J. Erle
The protein disulfide isomerase AGR2 is essential for production of intestinal mucus
PNAS, April 28, 2009; 106(17): 6950 - 6955.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
E. Di Valentin, C. Crahay, N. Garbacki, B. Hennuy, M. Gueders, A. Noel, J.-M. Foidart, J. Grooten, A. Colige, J. Piette, et al.
New asthma biomarkers: lessons from murine models of acute and chronic asthma
Am J Physiol Lung Cell Mol Physiol, February 1, 2009; 296(2): L185 - L197.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
V. Ramachandran, T. Arumugam, H. Wang, and C. D. Logsdon
Anterior Gradient 2 Is Expressed and Secreted during the Development of Pancreatic Cancer and Promotes Cancer Cell Survival
Cancer Res., October 1, 2008; 68(19): 7811 - 7818.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Z. Wang, Y. Hao, and A. W. Lowe
The Adenocarcinoma-Associated Antigen, AGR2, Promotes Tumor Growth, Cell Migration, and Cellular Transformation
Cancer Res., January 15, 2008; 68(2): 492 - 497.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
J. Shen, J. Liu, Y. Xie, B. A. Diwan, and M. P. Waalkes
Fetal Onset of Aberrant Gene Expression Relevant to Pulmonary Carcinogenesis in Lung Adenocarcinoma Development Induced by In Utero Arsenic Exposure
Toxicol. Sci., February 1, 2007; 95(2): 313 - 320.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
R. N. Morrison, G. A. Cooper, B. F. Koop, M. L. Rise, A. R. Bridle, M. B. Adams, and B. F. Nowak
Transcriptome profiling the gills of amoebic gill disease (AGD)-affected Atlantic salmon (Salmo salar L.): a role for tumor suppressor p53 in AGD pathogenesis?
Physiol Genomics, September 14, 2006; 26(1): 15 - 34.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. J. Holloway, D. S. Diyagama, K. Opeskin, J. Creaney, B. W.S. Robinson, R. A. Lake, and D. D.L. Bowtell
A Molecular Diagnostic Test for Distinguishing Lung Adenocarcinoma from Malignant Mesothelioma Using Cells Collected from Pleural Effusions
Clin. Cancer Res., September 1, 2006; 12(17): 5129 - 5135.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
C L Wilson, A H Sims, A Howell, C J Miller, and R B Clarke
Effects of oestrogen on gene expression in epithelium and stroma of normal human breast tissue.
Endocr. Relat. Cancer, June 1, 2006; 13(2): 617 - 628.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
F. R. Fritzsche, E. Dahl, S. Pahl, M. Burkhardt, J. Luo, E. Mayordomo, T. Gansukh, A. Dankof, R. Knuechel, C. Denkert, et al.
Prognostic Relevance of AGR2 Expression in Breast Cancer.
Clin. Cancer Res., March 15, 2006; 12(6): 1728 - 1734.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. Wang, A. Platt-Higgins, J. Carroll, S. de Silva Rudland, J. Winstanley, R. Barraclough, and P. S. Rudland
Induction of Metastasis by S100P in a Rat Mammary Model and Its Association with Poor Survival of Breast Cancer Patients
Cancer Res., January 15, 2006; 66(2): 1199 - 1207.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.